Sort
82,697 grants matching “vaccine development”
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination
$874,623Maya Mitchell · La Jolla Institute For Immunology · N01 · FY2022 · AI
Prenatal Factors and Risk of Schizophrenia in a Finnish National Birth Cohort
$874,545Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2010 · MH
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$874,385Shane P Crotty · La Jolla Institute For Immunology · R37 · FY2025 · AI
Parasite-Derived Vesicles in Babesia virulence and Vaccine Development
$874,372Choukri Ben Mamoun · Yale University · R56 · FY2024 · AI
HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses
$874,358Parham Ramezani-Rad · La Jolla Institute For Immunology · R61 · FY2025 · AI
A Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
$874,355Robert Juncosa · Thermal Gradient, Inc. · R44 · FY2013 · AI
Clinical Trials and Ancillary Assays
$874,348Harriet L Robinson · Geovax, Inc. · U19 · FY2011 · AI
HPV Serology
$874,335Leonard Freedmand · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA
Metabolic Studies of Mouse Models of Obesity and Diabetes
$874,327Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2010 · DK
Cellular Decision Making
$874,280Orion D Weiner · University Of California, San Francisco · R35 · FY2020 · GM
Cellular Decision Making
$874,159Orion D Weiner · University Of California, San Francisco · R35 · FY2019 · GM
Regulatory Compliance
$874,097David Beasley · University Of Texas Med Br Galveston · UC7 · FY2012 · AI
RESOURCE CORE
$874,020Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2017 · OD
Project-002
$873,905Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2020 · AI
UZ-UCSF CTU
$873,804Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2025 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$873,717Walter A. Orenstein · Emory University · N01 · FY2018 · AI
Papillomavirus-like Particles (VLP) as Broad Spectrum Human Papillomavirus (HPV) Vaccines
$873,677Joshua Weiyuan Wang · Pathovax, Llc · R44 · FY2019 · AI
Papillomavirus-like Particles (VLP) as Broad Spectrum Human Papillomavirus (HPV) Vaccines
$873,677Joshua Weiyuan Wang · Pathovax, Llc · R44 · FY2020 · AI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication
$873,644Sumit K Chanda · Salk Institute For Biological Studies · P01 · FY2010 · AI
Scanning Chlamydia proteome for vaccine antigens
$873,625Luis M De La Maza · Immport Therapeutics, Inc. · R42 · FY2010 · AI
COVID-19 Sample Collection and Vaccine Studies
$873,600Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
A novel strategy for vaccine-induced protection against maternal-to-fetal transmission of Zika virus
$873,588Sujan Shresta · La Jolla Institute For Immunology · R01 · FY2025 · AI
IMPACT OF FARMING ENVIRONMENT ON IMMUNE MATURATION AND RESPIRATORY HEALTH
$873,399James E. Gern · University Of Wisconsin-Madison · U19 · FY2016 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$873,331James L. Sorensen · University Of California, San Francisco · UG1 · FY2018 · DA
Identification of novel human antibodies and vaccines against influenza
$873,320James E Crowe · Vanderbilt University Medical Center · U19 · FY2019 · AI